|
Market Closed -
Australian S.E.
05:10:11 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.4500 AUD | +4.65% |
|
-3.23% | +25.00% |
| 10-23 | Starpharma Holdings Limited Announces Change of Address | CI |
| 10-20 | Starpharma Lifts Stake in Petalion Therapeutics to 66%, Gains Majority Control of Oncology Program | MT |
| Market Cap | 206M 145M 130M 120M 109M 203M 13.83B 1.43B 571M 7.24B 545M 533M 22.92B | P/E 2027 * |
-14.3x | P/E 2028 * | 95.6x |
|---|---|---|---|---|---|
| Enterprise Value | 179M 126M 113M 104M 94.22M 176M 12B 1.24B 496M 6.28B 473M 463M 19.89B | EV / Sales 2027 * |
28.4x | EV / Sales 2028 * | 6.39x |
| Free-Float |
69.55% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| SPL | Delayed | |
OTC Markets
| SPHRF | Delayed | |
|
Deutsche Boerse AG
| PQ6 | Delayed | |
|
Börse Stuttgart
| PQ6 | Delayed | |
|
Boerse Muenchen
| PQ6 | Real-time | |
|
Berne S.E.
| PQ6 | End-of-day quote |
| 1 day | +4.65% | ||
| 1 week | -3.23% | ||
| Current month | -48.28% | ||
| 1 month | -48.28% | ||
| 3 months | -40.00% | ||
| 6 months | -38.36% | ||
| Current year | +25.00% |
| 1 week | 0.42 |  | 0.49 |
| 1 month | 0.42 | | 0.87 |
| Current year | 0.33 | | 0.88 |
| 1 year | 0.32 | | 0.88 |
| 3 years | 0.08 | | 0.88 |
| 5 years | 0.08 | | 1.38 |
| 10 years | 0.08 | | 2.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 07/01/2024 |
Justin Cahill
DFI | Director of Finance/CFO | - | 02/04/2023 |
Jeremy Paull
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Thomas
CHM | Chairman | 81 | 12/06/2014 |
David McIntyre
BRD | Director/Board Member | 55 | 29/02/2020 |
Lynda Cheng
BRD | Director/Board Member | - | 31/07/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Expiration | Chief Executive Officer | -702,768 | 0.1473% | ||
| 11/08/26 | Buy | Chairman | 350,001 | 0.0734% | ||
| 11/08/26 | Buy | Director | 22,741 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.65% | -3.23% | +28.57% | +233.33% | 145M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.50% | +3.45% | +54.53% | +67.59% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +0.73% | +4.14% | +34.81% | +57.51% | 302B | |
| +2.80% | +4.66% | +6.98% | +31.36% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +2.44% | +1.48% | +43.71% | +96.79% | 417.7B | |
| Weighted average by Cap. | +2.15% | +3.04% | +50.70% | +96.50% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 6.3M 4.43M 3.97M 3.66M 3.32M 6.2M 422M 43.71M 17.44M 221M 16.64M 16.29M 700M | 26.25M 18.47M 16.55M 15.27M 13.81M 25.83M 1.76B 182M 72.66M 921M 69.33M 67.86M 2.92B |
| Net income | -16.25M -11.44M -10.24M -9.45M -8.55M -15.99M -1.09B -113M -44.98M -570M -42.92M -42.01M -1.81B | 1.71M 1.2M 1.08M 993K 898K 1.68M 114M 11.85M 4.73M 59.88M 4.51M 4.41M 190M |
| Net Debt | -27.25M -19.18M -17.18M -15.85M -14.34M -26.82M -1.83B -189M -75.44M -956M -71.98M -70.45M -3.03B | -38.53M -27.12M -24.29M -22.41M -20.28M -37.92M -2.58B -267M -107M -1.35B -102M -99.6M -4.28B |
Employees
50
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | A$0.4500 | +4.65% | 1,693,181 |
| 29/10/26 | A$0.4300 | -6.52% | 1,186,114 |
| 28/10/26 | A$0.4600 | +3.37% | 850,991 |
| 27/10/26 | A$0.4450 | -6.32% | 1,587,068 |
| 26/10/26 | A$0.4750 | +2.15% | 2,070,086 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.4300AUD
Average target price
1.220AUD
Spread / Average Target
+183.72%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
